SHILPA MEDICARE Fact Sheet, SHILPA MEDICARE Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHILPA MEDICARE Fact Sheet    (SHLAN)


RSVP REQUIRED: Your Invitation to Attend the Super Smallcaps Summit


Here is the latest financial fact sheet of SHILPA MEDICARE. For more details, see the SHILPA MEDICARE quarterly results and SHILPA MEDICARE share price and chart. For a sector overview, read our pharmaceuticals sector report.

SHILPA MEDICARE Price History

Price Rs 570.0
Mkt Cap Rs m 46,470
Vol '000 34.0
P/E X 72.9
P/CF X 23.0
EPS (TTM) Rs 7.8
% ch % -1.8
No. of shares m 81.53
% ch week % -6.5
% ch 1-mth % -0.0
% ch 12-mth % -1.3
52 week H/L Rs 671.0/317.1
(As on Sep 17, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SHILPA MEDICARE Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SHILPA MEDICARE EQUITY SHARE DATA
High Rs787749547539692 
Low Rs424401335191251 
Sales per share (Unadj.) Rs96.796.490.0111.4110.5 
Earnings per share (Unadj.) Rs13.813.514.419.018.1 
Diluted earnings per shareRs13.613.514.419.018.1 
Cash flow per share (Unadj.) Rs17.618.119.624.424.8 
Dividends per share (Unadj.) Rs0.600.701.001.101.10 
Adj. dividends per shareRs0.590.701.001.101.10 
Avg Dividend yield %0.10.10.20.30.2 
Book value per share (Unadj.) Rs123.2133.1146.9163.1181.4 
Adj. book value per shareRs121.1133.1146.9163.1181.4 
Shares outstanding (eoy) m80.1381.5381.5381.5381.53 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x6.36.04.93.34.3 
Avg P/E ratio x43.842.630.619.226.0 
P/CF ratio (eoy) x34.331.822.515.019.0 
Price / Book Value ratio x4.94.33.02.22.6 
Dividend payout %4.35.26.95.86.1 
Avg Mkt Cap Rs m48,48946,87635,95129,73938,458 
No. of employees `000NANANANANA 
Total wages/salary Rs m1,2791,4911,7641,9662,353 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SHILPA MEDICARE INCOME DATA
Net Sales Rs m7,7457,8617,3349,0799,011 
Other income Rs m293326156222401 
Total revenues Rs m8,0388,1877,4899,3019,412 
Gross profit Rs m1,5711,5121,7392,1452,325 
Depreciation Rs m306372421438540 
Interest Rs m31273746219 
Profit before tax Rs m1,5261,4401,4371,8841,968 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m420339262335488 
Profit after tax Rs m1,1061,1011,1751,5491,479 
Gross profit margin %20.319.223.723.625.8 
Effective tax rate %27.523.618.217.824.8 
Net profit margin %14.314.016.017.116.4 
SHILPA MEDICARE BALANCE SHEET DATA
Current assets Rs m7,2996,7195,4516,2399,181 
Current liabilities Rs m2,3692,6672,5344,1086,022 
Net working cap to sales %63.751.539.823.535.1 
Current ratio x3.12.52.21.51.5 
Inventory Days Days158109392027 
Debtors Days Days81102101992902 
Net fixed assets Rs m7,4238,59710,65013,65417,195 
Share capital Rs m8082828282 
"Free" reserves Rs m9,78910,76911,89413,21214,705 
Net worth Rs m9,86910,85011,97613,29414,787 
Long term debt Rs m1,4256818111,6504,805 
Total assets Rs m14,72215,31616,10019,89226,376 
Interest coverage x49.755.140.142.310.0 
Debt to equity ratio x0.10.10.10.10.3 
Sales to assets ratio x0.50.50.50.50.3 
Return on assets %7.77.47.58.06.4 
Return on equity %11.210.19.811.710.0 
Return on capital %13.812.711.512.911.2 
Exports to sales %56.90000 
Imports to sales %40.531.622.320.924.8 
Exports (fob) Rs m4,4070000 
Imports (cif) Rs m3,1342,4861,6331,9002,231 
Fx inflow Rs m4,6914,2263,9875,2065,078 
Fx outflow Rs m3,4502,6531,7682,1383,322 
Net fx Rs m1,2411,5732,2193,0691,756 
SHILPA MEDICARE CASH FLOW
From Operations Rs m 375 449 1,468 1,244 471 
From Investments Rs m -2,622 -84 -1,962 -2,895 -4,043 
From Financial Activity Rs m 3,127 -612 101 1,755 4,364 
Net Cashflow Rs m 929 -261 -395 102 790 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 53.3%
Institution 18.1%
Non-Institution 28.7%
Total 100.0%
Free Float 46.8%
Pledged promoter holdings 0.8%
 

Company Information

REGD OFF Shilpa House, #12-6-214/ A1, Hyderabad Road, Raichur - 584135
E-MAIL info@vbshilpa.com WEB www.vbshilpa.com
TEL 08532-238704 FAX 08532-238876
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
YEAR OF INC: 1987 BSE CODE: 530549 FV (Rs): 1 DIV YIELD (%): 0.2

More Pharmaceuticals Company Fact Sheets:   ZIM LABORATORIES  TRIMURTHI DRUGS  PANCHSHEEL ORG  ARTEMIS MEDICARE SERVICES  TOHEAL PHARMA  

Compare SHILPA MEDICARE With:   ZIM LABORATORIES  TRIMURTHI DRUGS  PANCHSHEEL ORG  ARTEMIS MEDICARE SERVICES  TOHEAL PHARMA  




Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading (Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SHILPA MEDICARE

  • Track your investment in SHILPA MEDICARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SHILPA MEDICARE

SHILPA MEDICARE - ADCOCK INGRAM COMPARISON

COMPARE SHILPA MEDICARE WITH

MARKET STATS